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Pcp1p is a rhomboid protease in the inner mitochondrial membrane of S. cerevisiae
that processes Mgm1p, a protein required for mitochondrial fusion. In this study, five
previously generated pcp1 mutant strains were analyzed for mitochondrial respiration,
genome maintenance, and tubularization. We found that mutations that introduced a
charged residue into Pcp1p resulted in a higher degree of respiratory deficiency, mtDNA
loss, mitochondrial fragmentation, and possible mitochondrial membrane potential loss.
Furthermore, these mutant phenotypes paralleled an increase in an aberrant form of
Mgm1p that accumulates in the absence of wild type Pcp1p. This raises questions about
the biogenesis of aberrant Mgm1p and its involvement in disrupting normal
mitochondrial fusion. The findings outlined herein will help to establish a cascade of
events that lead from loss of proper Mgm1p cleavage to associated cellular defects.
Complete understanding of these connections will be valuable in establishing a similar
cascade in the human disease ADOA.
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CHAPTER I
INTRODUCTION
It is an extremely well understood concept in all fields of science that involve
biological systems that single cells are the most basic forms of life from which all other
life on Earth evolved. All known unicellular and multicellular forms of life can be
categorized into one of three domains: Bacteria, Archaea, and Eukaryota. Eukaryotes are
considered to be the most complex, as they contain a nucleus and other membrane-bound
organelles, such as mitochondria, endoplasmic reticulum, chloroplasts, and lysosomes.
Membrane-bound organelles have specialized functions and are compartmentalized
subunits within a cell that are usually separated from the rest of the cell’s contents by a
lipid bilayer.
Saccharomyces cerevisiae is a single celled eukaryotic organism that is used as a
model system to explore complex biological processes in a simplified setting. Due to
evolutionary relationships, S. cerevisiae possesses the same basic cellular physiology as
higher eukaryotic cells, such as mammalian cells. With the exception of erythrocytes, all
eukaryotic cells contain membrane bound organelles with distinct roles in maintaining
cellular viability. The mitochondrion is a conserved organelle with multiple important
functions, including the production of energy and metal cofactors needed for enzyme
activity. The basic principles that regulate the morphology and function of mitochondria
are also similar among eukaryotes. Although the dynamics of mitochondrial biogenesis
1

are conserved from S. cerevisiae to humans, the rapid doubling time, high transformation
efficiency, ease of genetic manipulation, and viability without mitochondrial DNA in S.
cerevisiae makes them desirable for use in mitochondrial research. In both cases, there is
a network of mitochondria whose lipid membranes undergo fusion and fission, but the
protein interactions at the biochemical level that enable these events are not completely
understood. Here we introduce new data about the biochemical pathway that links the S.
cerevisiae proteins Pcp1p and Mgm1p to mitochondrial structure and function. By
understanding this relationship, we expect to further the basic comprehension of the
molecular events that govern mitochondrial fusion in higher eukaryotes.
Vision impairment is a debilitating affliction that can affect people of all generations,
especially the elderly. Optic atrophy is a common cause of vision impairment that occurs
when the optic nerve fibers that transmit visual information from the retina to the brain
begin to degenerate. Autosomal dominant optic atrophy (ADOA) is the most common
genetic form of this condition, with disease prevalence between 1/10,000 and 1/30,000
and average penetrance about 70%. Symptoms of ADOA often begin to appear by age
ten and can vary from normal vision to legal blindness as well as color vision deficiency.
Although stem cell therapies show potential, no treatments for optic atrophy have been
developed, so research that characterizes the biochemical pathway of ADOA is critical.
Mutations in OPA1 and OPA3 are known to cause ADOA and disrupt energy metabolism
in the mitochondria (Guy Lenears et al., 2012). The baker’s yeast, Saccharomyces
cerevisiae, expresses a homologous protein called Mgm1p with similar structure and
function to the one encoded by OPA1 (Delettre et al., 2000). In this study, S. cerevisiae
was used to characterize mitochondrial phenotypes that arise from disrupting the
2

production of a mature form of the yeast homolog of OPA1. The information gathered
and conclusions made from studying a yeast homolog of OPA1 are medically relevant as
they are translatable to characterization of human biochemical pathways involving human
OPA1 and other proteins with similar function. Extensive characterization of these
proteins is essential to developing treatment for ADOA and other mitochondrial-related
diseases.
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CHAPTER II
BACKGROUND AND PRELIMINARY DATA
Saccharomyces cerevisiae as a model organism
In this study, Saccharomyces cerevisiae was used to model phenotypic and genotypic
mitochondrial mutations that may be observed in subjects with autosomal dominant optic
atrophy (ADOA). S. cerevisiae, or baker’s yeast, is valued as a eukaryotic model system
largely because the entire S. cerevisiae genome has been completely sequenced since
1996 and is now publicly available on the Saccharomyces Genome Database (SGD
Project). Because the cost and difficulty of genetic manipulation in yeast is lower than in
mammalian systems, the yeast genome has been extensively characterized. For example,
site-specific homologous recombination can be used to modify desired loci in the S.
cerevisiae genome, including the generation of interruption and/or deletion mutations as
well as the introduction of additional DNA (Joska et al., 2013). It is also relatively
straightforward to transform plasmids with selectable markers into yeast. Plasmids can
then be selected for or against by plating cells onto selectable media in a process called
shuffling. Since the 1996 publication of the S. cerevisiae genome, a library of yeast
mutants with targeted deletions of all nonessential open reading frames has been
compiled through a concerted effort from the scientific community of yeast researchers
(Gieaver et al., 2002). In addition, there is a compelling level of conservation between
yeast and higher eukaryotes of basic and specific biological processes including
regulation of the cell cycle, DNA replication and repair, protein trafficking, and
mitochondrial metabolism and dynamics. There are numerous proteins encoded in S.
cerevisise that have human homologs with which they share functional and sequence
4

similarity. For example, the ADOA disease gene, OPA1, is orthologous to the yeast gene
MGM1. Furthermore, there is a basic comprehension of the physiological significance of
more protein coding regions in the Saccharomyces cerevisiae genome than in other
eukaryotes, and about one thousand of those are orthologous to human disease genes. In
fact, the majority of these human orthologs are also functional in yeast (Botstein and
Fink, 2011). Extensive understanding of the S. cerevisiae proteome has been made
possible by additional libraries of GFP and antigen tagged proteins, which have enabled
visualization of protein localization by live cell imaging and immunoprecipitation
approaches towards analyzing protein-protein interactions. The strains in each of these
libraries are readily available to the scientific community, supporting the use of S.
cerevisiae as a model organism. Yeast cells are also viable without mitochondrial DNA,
so long as they are provided with a fermentable carbon source (Shadel, 1999). This
makes them invaluable to scientists who study defects in biological pathways that give
rise to mutations or deletions in the mitochondrial genome.
Another valuable aspect of using S. cerevisiae as a eukaryotic model is its rapid
doubling time of 90 minutes, compared to other eukaryotic cells, like human epithelium,
which double about every 25 hours (Buehring and Williams, 1976; Sherman, 1991). This
is convenient for numerous laboratory procedures. For example, when isolating protein
or DNA to test gene expression or to prepare for PCR, usable cell populations can be
grown overnight before a protocol is performed. Additionally, when shuffling and
unshuffling plasmids, the rapid passage of multiple generations allow for timely
confirmation of the presence of a selectable marker in a cell culture.

5

The mitochondrion
The mitochondrial network is a connection of compartmentalized, tubular organelles,
which are responsible for generating the vast majority of ATP in eukaryotic organisms.
They are sectioned into an outer membrane lipid bilayer, an inter-membrane space, an
inner membrane lipid bilayer that folds into cristae, and a matrix. Each compartment
hosts specialized proteins and biomolecules that are necessary for various mitochondrial
functions, including energy metabolism through the electron transport chain, ß-oxidation
of fatty acids, and the Krebs cycle, calcium ion storage, steroid and heme synthesis,
hormonal and ROS signaling, and regulation of the cell cycle, proliferation, and
apoptosis. Mitochondria contain their own DNA that is separate from the genomic DNA
of the nucleus and is structurally and metabolically similar to bacterial DNA. In fact, the
endosymbiotic theory is the most accredited theory of mitochondrial origin and suggests
that mitochondria were once aerobic bacteria that were engulfed by anaerobic eukaryotes,
allowing the eukaryotes to survive in aerobic conditions (Mereschkowsky, 1905;
translated by Martin and Kowallik, 2010). Proteins encoded by the mitochondrial
genome vary among eukaryotic species, but all mitochondrial genomes have their own
DNA replication and repair machinery apart from their nuclear versions. The S.
cerevisiae mitochondrial genome encodes twenty-four tRNAs corresponding to all
codons, 21S and 15S rRNAs, a ribosomal protein (var1), the subunits of cytochrome c
oxidase, three ATP synthase subunits, apocytochrome b, and an RNA component of
RNase P (Foury et al., 1998). Since WT mitochondria are interconnected tubules, one
network of mitochondria may have multiple copies of the mitochondrial genome (Satoh
and Kuroiwa, 1991). The morphologies of these networks are established and maintained
6

by a variety of proteins that mediate mitochondrial membrane fusion and fission. Given
the primary role of mitochondria in ATP generation and the high demand of energy in
neurons and myocytes, mitochondrial or nuclear DNA mutations that adversely affect
energy metabolism are the cause of a multitude of neurological and muscular disorders,
including autism and myopathy (Frye and Rossignol, 2011). Additionally, the
mitochondrial free radical theory of aging proposes a link between oxidative stress from
mitochondrial respiration and damage to mitochondrial DNA and proteins, which leads to
further accumulation of ROS and cell, organ, and systemic degeneration associated with
aging (Miquel et al., 1980).

Pcp1p and Mgm1p structure and function
Pcp1p is a multi-spanning transmembrane protein embedded in the inner
mitochondrial membrane of Saccharomyces cerevisiae, where it assumes is catalytic role:
Ccp1p and Mgm1p processing (McQuibban and Freeman, 2003; Esser et al., 2002).
Pcp1p is also required for ATP synthase complex assembly and cytochrome c
accumulation in the cristae (Amutha et al., 2004). This project focuses exclusively on the
relationship between Pcp1p and Mgm1p. As a rhomboid serine peptidase, the active site
of Pcp1p contains a nucleophilic serine embedded in the fourth of six transmembrane
domains and an active site histidine at position 313 in the sixth transmembrane helix,
forming a catalytic dyad in the inner membrane where Pcp1p processes other
transmembrane proteins. Hydrogen bonding between the nitrogen of histidine and
hydrogen of serine increase electron density on the serine oxygen, promoting a
nucleophilic attack of a peptide bond on the substrate, Mgm1p (Uritsky et al., 2012).
7

Pcp1p is known to impact mitochondrial genome maintenance and morphology through
its interaction with the dynamin-like GTPase Mgm1p, which mediates inner membrane
fusion between adjacent mitochondria, forming a network of interconnected tubules.
Strains deleted for PCP1 are phenotypically indistinguishable from MGM1 deletion
mutants, displaying abnormal mitochondrial morphology and loss of mitochondrial DNA
(Herlan et al., 2003). Mgm1p exists in a long, membrane-tethered form, l-Mgm1p, that is
cleaved by Pcp1p in the inner membrane to form a short form, s-Mgm1p, which assumes
its biological role in the intermembrane space. It has been shown that only an active
GTPase domain of the short form is required for membrane fusion, and l-Mgm1p is
merely a membrane tether for s-Mgm1p (DeVay et al., 2009). It has also been shown
that s-Mgm1p self-associates to connect inner membranes, promotes membrane bending,
and undergoes GTP-dependent conformational change that promotes cristae formation
and inner membrane fusion (Rujiviphat et al., 2015). Pcp1p is analogous to PARL in
humans, which processes OPA1, the human ortholog of Mgm1p (Duvezin-Caubet et al.,
2007). PARL controls apoptosis through this processing pathway, as active OPA1
prevents secretion of the apoptotic-signaling molecule caspase activator cytochrome c
from cristae into the intermembrane space in addition to membrane fusion catalysis.
Mutations in OPA1 lead to degradation of mitochondrial DNA, abnormal mitochondrial
morphology, and misregulation of apoptosis that culminate in degeneration of optic nerve
fibers, resulting in vision impairment known as autosomal dominant optic atrophy
(ADOA) (Amati-Bonneau, et al., 2007).
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Mutant pcp1 screening
The aim of this project was to characterize the impact various PCP1 point
mutants had on mitochondrial genome maintenance and morphology in S. cerevisiae.
Multiple pcp1 mutants were previously generated using hydroxylamine mutagenesis and
five were selected based on a single amino acid mutation and the consistent phenotype
they induced (Xiao, 2013). The five single amino acid mutations were G233D, S252N,
G233S, G315D, and G120R. Presence of Pcp1p was confirmed in each of these mutants.
The five mutants and two controls, PCP1 and ∆pcp1, were each indirectly checked for
Pcp1p activity based on their ability to grow on the non-fermentable carbon sources
ethanol and glycerol (EG) as shown in Figure 2.1. Pcp1p functionalities reflected by
growth on EG and Mgm1p processing are reported in Table 2.1 (Gordon lab, unpublished
data).

-His Glu

-His EG

-Ura Glu

PCP1

Δpcp1
G233D
G233S
G120R
G315D
S252N

Figure 2.1

Growth characteristics of pcp1 mutants by spotting assay

Haploid Pcp1p mutants exhibit variable growth on non-fermentable carbon. A six-point
10-fold serial dilution of each strain was plated to -His glucose (fermentable) and -His
EG (non-fermentable) to characterize growth patterns of the His-marked pcp1 plasmids.
Reduced growth on non-fermentable glycerol plates was used to predict defects in
cellular respiration. Photographs were taken after 72 hours of growth at 30˚C. The
absence of growth on -Ura glucose confirms loss of the covering wild type (WT) PCP1
plasmid.
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Table 2.1

Tabulated growth for Pcp1p mutants

Mutation
Growth on EG
Growth on
Glucose

PCP1 ∆pcp1 G233D G233S G120R G315D S252N
+++
+
+++
+++
+++
+++
++
++
+++
+++
++
+++

The growth of each strain shown in Figure 2.1 was scored relative to WT growth on EG
and glucose using the following scale: +++; WT growth, ++; reduced growth, +; minimal
growth, -; no growth.
The electron transport chain (ETC) is the cell’s primary source of energy production,
but when it is unavailable due to hypoxia or a defect in the ETC the cell relies on
fermentation to generate much of its ATP and to regenerate NAD from NADH for use in
glycolysis (Alberts et al., 2014). Providing yeast with only EG prohibits fermentation
and ensures that the ETC must be used to generate the energy required for viability.
Pcp1p is required for a functional ETC, and therefore, growth is interpreted as evidence
of a functioning ETC and Pcp1p.

Pcp1p catalytic activity
Data indicating Pcp1p catalytic activity in each of these mutants were previously
gathered by confirming production of processed Mgm1p (s-Mgm1p). Mgm1p was
detected using Western blotting as shown in Figure 2.2. The impact of each amino acid
mutation on catalytic activity of Pcp1p was indirectly measured by analyzing
downstream mutant phenotypes and comparing them to the WT strain.
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WT

∆pcp1

S252N G233S G315D

G233D G120R

97kD

l-Mgm1p
s-Mgm1p
s-Mgm1p*

45kD

Pgk1p

1
Figure 2.2

2

3

5

4

6
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Catalytic activity of Pcp1p

Pcp1p mutants have variable defects in Mgm1p substrate processing. A volume of cells
equal to 1 OD600 was harvested by centrifugation and total protein isolated by alkaline
lysis. Protein lysate was electrophoresed through a 7% SDS PAGE, transferred to a
nitrocellulose membrane, and probed with anti-HA antibodies followed by HRP
conjugated secondary antibodies. Antibodies against Pgk1p were used as a control for
equal loading.
As expected, the only forms of Mgm1p in WT are s-Mgm1p (processed) and lMgm1p (unprocessed). Interestingly, in the absence of WT Pcp1p there is accumulation
of an isoform of Mgm1p that is smaller than l-Mgm1p but larger than s-Mgm1p. This is
evident in lane 2, labeled ∆pcp1, where the faster migrating protein band migrates slower
than fastest migrating band in lane 1. This incorrect processing of the long form of
Mgm1p generates an aberrant form of s-Mgm1p*, most likely by another protease that
recognizes a cleavage site in Mgm1p. Because the G315D mutant also has only this
incorrectly processed short form of Mgm1p, the mutated Pcp1p in this strain was
postulated to be “nonfunctional.” Since the G120R and G233D mutants appear to have
similar levels of both the correctly and incorrectly processed short forms of Mgm1p, it is
likely that they result in a “partially functional” phenotype, while the G233S and S252N
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mutants show very low or nonexistent levels of s-Mgm1p*. The “functional” G233S and
S252N mutants were predicted to have the most similar phenotypes to WT.

Hypothesis
Mitochondrial membrane fusion and maintenance of the mitochondrial genome are
intertwined phenomena that depend on the rhomboid protease, Pcp1p, and one of its
substrates, Mgm1p. Mgm1p exists in the mitochondria as a long form (l-Mgm1p) and a
short form (s-Mgm1p), which are thought to function co-dependently as an anchor to the
inner membrane and a GTPase-dependent catalyst, respectively, to promote membrane
fusion of adjacent mitochondria (Michael Zick et al., 2009). Cleavage of l-Mgm1p to
s-Mgm1p by Pcp1p occurs in the mitochondrial inner membrane and is necessary for
mitochondrial genome maintenance and proper formation of tubular mitochondrial
networks. Furthermore, ∆pcp1 and ∆mgm1 mutants show extensive fragmentation of
their mitochondria and respiratory deficiency (McQuibban et al., 2003). The primary
structure of an enzyme allows highly specific, thermodynamically favorable polar and
non-polar interactions among regions of the enzyme, between the enzyme and its
substrates, and between the enzyme and its environment. Secondary and tertiary
structures are dependent on these interactions and dictate the function of the enzyme. In
Pcp1p, disruption of the interactions may lead to loss in protease activity resulting in
impaired mitochondrial function. In this project, I investigated the effect that single
amino acid mutations in Pcp1p (G233D, G233S, G120R, G315D, and S252N) had on
processing of Mgm1p, mitochondrial DNA (mtDNA) maintenance, respiratory
efficiency, and mitochondrial morphology. Considering the relationship between amino
12

polar and nonpolar amino acid interactions and protein structure and function, I
hypothesized that mutations which introduced a charged amino acid into hydrophobic
transmembrane domains, especially near the active site side chains, are likely to have the
most drastic impacts on the cells, resulting in higher degrees of loss in catalytic activity,
mtDNA, respiratory efficiency, and tubular mitochondria than amino mutations which
retained polar and nonpolar interactions among amino acids.
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CHAPTER III
MATERIALS AND METHODS
Strains and media
All yeast strains used in this study are derivatives of the BY4741 background and are
listed in Table 6.1. Plasmid descriptions are provided in Table 6.2. Plasmids were
introduced into yeast following the 0.1M LiAc-TE, 40% PEG3000-based transformation
protocol as described (Daniel and Woods, 2002). YPD (1% Bacto-yeast extract, 2%
Bacto-peptone, 2% Dextrose), YPEG (1% Bacto-yeast extract, 2% Bacto-peptone, 3%
Ethanol (v/v) Glycerol, 2% (v/v)), and synthetic complete (0.67% Bacto-yeast nitrogen
base, 2% Dextrose, 2% Bacto-agar, appropriate supplements) media were generated as
described (Sherman, 1991). Various amino acids were dropped out of synthetic complete
media to maintain selection for marked plasmids. The pcp1 mutant stocks were frozen
at -80˚C with covering URA3 marked plasmids encoding WT PCP1. The URA3 marked
plasmid was removed by plating onto media containing 5-fluoroorotic acid (5-FOA) for
three days as described (Sherman, 1991).
Yeast TRP1 deletion mutant construction
The TRP1 gene (YDR007w) was deleted by replacement based homologous
recombination as described (Longtine et al., 1998). Briefly, TRP1 F1 and TRP1 R1
primers (Table 3.1) were used with the plasmid pDG271 as the template in a PCR reaction
to generate an ~1,550 base pair fragment that contained the kanamycin resistance marker
14

flanked by 40 base pairs homologous to the 5’ and 3’ ends of the TRP1 gene. The PCR
product was transformed into DGY43 and stable integration events selected on YPD
media supplemented with 0.2g/L G418. Correct genomic integration events were
identified by PCR analysis of genomic DNA using KanR antisense and TRP1 check
primers (Table 3.1) and confirmed by the strain’s inability to grow on plates lacking the
amino acid tryptophan.
Table 3.1
Primer
KanR
TRP1 check
TRP1 F1
TRP1 R1

Primers used to generate TRP1 auxotroph
Sequence (5’-3’)
GCTCGCAGGTCTGCAGCGAGGAGCCG
CTATTGAGCACGTGAGTATAC
ATGTCTGTTATTAATTTCACAGGTAGTTCTGGTCCATTGGTGC
GGATCCCCGGGTTAATTAA
TCTCCATGCAGTTGGACGATATCAATGCCGTAATCATTGACC
GAATTCGAGCTCGTTTAAAC

Construction of mtGFP plasmid
To visualize mitochondrial morphology, a TRP1-marked plasmid containing
mitochondrial targeted green fluorescent protein (GFP) expressed under the constitutive
GPD promoter (YGR192c) was constructed using the Gibson Assembly Cloning kit as
described by the manufacturer (NEB). Briefly, 20ng of double-stranded DNA coding for
GFP-PUT2(1-17) (synthesized by IDT) were mixed with 50ng of XbaI-cut pDG123
vector and 10µl Gibson Assembly Mastermix in a 20µl reaction. Five microliters of the
reaction volume were transformed into NEB 5-alpha Competent E. coli and cells
containing intact recombinant plasmid were selected on LB plates containing 100µg/ml
ampicillin (LB/Amp). Putative clones were inoculated in 3mL of LB/Amp liquid media
and grown at 37˚C overnight. Recombinant plasmids were isolated by alkaline lysis and
15

the isolated plasmids analyzed by restriction digestion with XbaI, EcoRI, and HindIII
followed by electrophoresis through a 0.5X TBE 0.8% agarose gel (Sambrook and Russel
2001). Plasmids with the expected restriction pattern were sent for sequencing (DNASU
Sequencing Core, Arizona State University). E. coli containing correct plasmid constructs
were named pDG370 and pDG371 and stored at -80˚C.

Western blotting for GFP expression
The recombinant mitochondrial-targeted GFP plasmid (pDG371) was transformed into
yeast strains DGY519-525, which contained a URA3-marked plasmid encoding PCP1 in
addition to a HIS3-marked plasmid encoding the different pcp1 constructs to be tested.
The URA3-marked plasmid was subsequently removed by streaking the transformed
strains onto media containing 5-FOA. Following three days of growth on 5-FOA,
unshuffled strains were grown overnight in -Trp selective liquid media at 30˚C. A volume
of culture equivalent to 2 OD600 of cells from each strain was isolated by centrifugation
and total cellular protein was isolated by alkaline lysis as described (Riezman et al., 1983).
Ten microliter aliquots of total protein lysate (50µl total) from each of the strains were
electrophoresed through a 15% SDS-PAGE at 18mA and room temperature for 2 hours 45
minutes and the protein transferred onto nitrocellulose at 4˚C and 70V for 3 hours. The
membrane was stained with amido black to confirm equal protein loading and even
transfer. The western analysis was carried out according to the described protocol
(Harlow and Lane, 1988). Briefly the membrane was blocked by rocking for 10 minutes
in 5% nonfat dry milk (w/v) in 1X TBS+0.1% Tween-20. Primary antibodies generated in
mouse against GFP and Pgk1p were added at 1/5000 and 1/8000 fold dilutions,
16

respectively, and the membrane rocked for 1 hour at room temperature. After washing
four times for 15 minutes each with 1XTBS+0.1%Tween-20, the secondary anti-mouse
HRP antibody was added at a 1/8000-fold dilution, and the solution was rocked for 1 hour
at room temperature. The membrane was rinsed 4 times with 1XTBS+0.1%Tween-20 for
15 minutes each and developed by enhanced chemiluminescence (Pierce).

Fluorescence microscopy of mtGFP
Three milliliters of uncovered DGY519-525 yeast strain cultures were grown
overnight in -Trp selective media at 30˚C with shaking. The following day all strains
were spotted in 3µl aliquots onto microscope slides and viewed through a GFP filter under
100X oil emersion on a Nikon Eclipse-50 microscope. Images of at least 200 cells from
each strain were captured under the same exposure settings with QCapture Pro software.
The percentages of cells containing GFP localized to tubular mitochondria, fragmented
mitochondria, or the cytosol were determined. A cell that had at least one tubular
mitochondrial structure was classified as tubular, a cell lacking tubular mitochondria was
classified as fragmented, and a cell containing no mitochondrial GFP fluorescence was
classified as cytosol.

Isolation of genomic DNA
Five-milliliter volumes of selective media were inoculated with DGY539-545 and
DGY24 and grown to saturation overnight at 30˚C with shaking. Total DNA was isolated
from each culture equivalent to 15 OD600 (Hoffman and Winston, 1987). Briefly, volumes
17

containing 15 OD600 of cells were pelleted at 20,400g for 5 minutes, washed with sterile
water, and resuspended in residual liquid. To each cell pellet, 0.2ml of lysis mix (2%
Triton X-100, 1ml 1% SDS, 0.1M NaCl, 10mM Tris pH 8, 1mM EDTA), 0.2ml
phenol:chloroform:isoamyl alcohol (25:24:1), and 0.3g acid washed glass beads were
added then vortexed at room temperature for 2-4 minutes. A volume of 0.2ml TE pH 8.0
was added and the mixture centrifuged for 5 minutes at 20,400g. The aqueous layer was
added to 1ml of 100% ethanol, mixed by inversion, incubated at 20˚C for 1 hour, and then
centrifuged at 20,400g for 5 minutes. The nucleic acid pellet was resuspended in 0.4ml
TE pH 8.0 containing 3µl 10mg/ml RNase A and samples incubated at 37˚C for 30
minutes with shaking. To precipitate the remaining nucleic acid, 1/10 volume of 3M
sodium acetate pH 5.2, and 2.5 volumes of 100% ethanol were added to the mixture and
incubated at -20˚C for 30 minutes. The mixture was centrifuged for 5 minutes at 20,400g,
and the pellet was air-dried prior to resuspension in 50µl TE pH 8.0. The isolated DNA
was quantified spectrophotometrically at OD260 using quartz cuvettes.

mtDNA/nDNA ratio by qPCR
A 20µl qPCR reaction containing 2ng template DNA, 1X-DyNAmo HS SYBR Green
PCR (Thermo Scientific), and individual gene-specific primers was carried out using
StepOnePlusTM Real-Time PCR system (Applied Biosystems) with the following PCR
parameters:
1. 95˚C for 15 minutes
2. 55˚C for 15 seconds
3. 60˚C for 1 minute (Repeat 2-3 for 40 cycles)
18

Data was collected during the 60˚C incubation step.
Primers were used at the following final concentrations: 125pM for ACT1, COX3,
TIM11, and ATP6; 250pM for COX1. Each strain was analyzed in triplicate using both
mitochondrial and nuclear primers. The mean Ct from each triplicate was used in
determining mtDNA/nDNA fold change. A melt curve of the PCR product was generated
at the end of each reaction to confirm single product amplification. This process was
repeated three times for each mitochondrial primer, in one biological replicate. A standard
curve plotting mass of DNA template versus Ct from a 5-point 10X serial dilution of DNA
was generated from data collected on each plate for ACT1 and the mitochondrial target.
The slope of the standard curve derived from each plate was used to calculate efficiency of
the qPCR reactions on that plate with the following equation:
E = 10-1/slope
% Efficiency = (E-1)×100
Efficiency (E) was determined for ACT1 and mitochondrial targets. Using the
Pfaffl method, the fold change (FC) of mtDNA between each strain and WT were
determined as described (Pfaffl, 2001). Only data from qPCR reactions having 102% >
efficiency > 85% were included in these calculations. Briefly, using ACT1 as the
reference target, the efficiency of each qPCR reaction and median Ct values were used to
determine mtDNA/nDNA ratios with the following equation:
∆Ct = Ct (WT) − Ct(mutant) (determined for ACT1 and mitochondrial targets)
Relative Copy Number (RCN) = E∆Ct
Fold Change (FC) =

! ∆!" (!"#$%!!"#$%&' !"#$%!)
! ∆!" (!"#!)
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To measure precision of qPCR, this process was also used to calculate the FC when
comparing two different nuclear genes: TIM11/ACT1 and TUB2/ACT1.
The primer sequences used for qPCR in this study are listed in Table 3.2.
Table 3.2
COX1
COX3
ATP6
ACT1
TIM11
TUB2

qPCR primer sequences
Forward (5’-3’)
TGAGAACAAATGGTATGACAATGC
ATTGAAGCTGTACAACCTACCGAATT
GGTACACCATTACCATTAGTACCT
GGTTGCTGCTTTGGTTATTG
TGCTAAGAAGAAAGAGGAGCAG
TACCGTTGCAGCCTTCTTTAG

Reverse (5’-3’)
ATTGTAATACCAGCAGATAATAC
CCTGCGATTAAGGCATGATGA
ATGACCAGCTAAGATATTAGAACCT
CTTGGTGTCTTGGTCTAC
GTTACTACAGGGTGTAGCTTGG
GGGATCCATTCCACGAAATAGT

DAPI staining
Cultures for DGY539-545 and DGY24 were grown overnight in selective media at
30˚C, fixed in formaldehyde, and processed for DAPI staining. Briefly, 1/10 volume
(300µl) of 37% formaldehyde was added to 3mL of cells from an overnight culture. The
mixture was rocked for 2 hours at room temperature. The cell pellet was isolated by
centrifugation at 800g for 10 minutes, washed with sterile distilled water, repelleted as
described, and the final pellet resuspended in 300µl PBS. Cells were permeabilized in
70% ethanol on ice for 30 minutes. Permeabilized cells were pelleted at 800g for 10
minutes and resuspended in PBS. Twenty microliters of cells were incubated with 10µg
of DAPI in 180µl of sterile distilled water on ice for 5 minutes. The DAPI-stained cells
were pelleted at 20,400g for 2 minutes, resuspended in sterile distilled water, and 3µl
aliquots were spotted onto a glass microscope slide, and viewed under 100X oil emersion
on a Nikon Eclipse-50 microscope. Images of at least 200 cells from each strain were
captured using the same exposure settings with QCapture Pro software. The percentages
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of cells containing mtDNA were determined, with a cell containing any extra-nuclear
DAPI staining scored as containing mtDNA.
Petite frequency determination
Three milliliters of DGY539-545 cell cultures were grown overnight in -His liquid
media at 30˚C. The next morning, a volume of cells equivalent to 0.3 OD600 (107 cells)
were diluted into a 1ml volume and serial diluted to achieve 1000 cells/ml. Multiple
100µl aliquots of this dilution from each strain were plated onto -His glucose plates and
incubated at 30˚C. After 3 days, the numbers of colonies on each plate were counted and
the colonies replica printed onto -His EG plates using velvet. The replica plates were
incubated at 30˚C for another 3 days, and the numbers of colonies that grew on -His EG
plates were counted. This process was independently repeated five times for each strain.
The petite frequency of each strain was determined using the following equation:
Petite frequency =

# !"#"$%&' !" !"#$%&'!# !"#"$%&' !" !"
# !"#"$%&' !" !"#$%&'

× 100

Serial dilution spotting assay
Cells (DGY539-545) were grown in -His selective media overnight with shaking at
30˚C. The next morning, a volume equivalent to 107 cells was harvested by centrifugation
and the resulting cell pellet resuspended in 100µl sterile water to achieve 105 cell/µl. Cells
were placed in the first column of a 96-well microtiter plate and 10-fold serially diluted by
transferring 10µl of sample into 90µl of water. This dilution was repeated to achieve a
final concentration of 10 cells/µl. Three microliters of sample from each well were
spotted onto selective plates and incubated at the indicated temperatures for up to 72
hours.
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CHAPTER IV
RESULTS
Growth on non-fermentable carbon
Metabolism of the non-fermentable carbon sources ethanol and glycerol requires
cofactors (NAD and FAD) that are generated by the electron transport chain (Berg et al.,
2015 A; Berg et al., 2015 B). As a qualitative measurement of the impact that these single
amino acid mutations had on electron transport chain functionality, growth on media
containing the non-fermentable carbon source EG was compared among seven strains,
DGY539-545 (Figure 4.1). As these mutants were initially identified in a temperature
sensitive screen for pcp1 activity, growth characteristics were reconfirmed at both 30˚C
and 37˚C (Xiao, 2013).
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Figure 4.1

Growth profile of pcp1 mutants by spotting assay
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Figure 4.1 continued
Reduction in growth on non-fermentable carbon (EG) likely reflects loss in ETC function
for several pcp1 mutations. A five-point 10-fold serial dilution of each strain was spotted
onto A) -His glucose plates and B) -His EG plates. Growth patterns at both 30˚C and
37˚C were characterized after 48 and 72 hours.
As shown in Figure 4.1A, all strains grew on glucose containing plates, although the
∆pcp1 and G315D mutants exhibited a slightly slower growth profile at both of the
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temperatures tested. These differences were more pronounced when comparing growth on
EG containing plates (Figure 4.1B). The strain containing mutated Pcp1p (G233D) had
reduced growth, while no growth on EG was detected for both the strain lacking Pcp1p
and the strain expressing the G315D mutation. Yeast strains containing plasmids
encoding WT Pcp1p or plasmids encoding mutant Pcp1p with amino acid changes G233S,
S252N, or G120R, grew normally on EG at all dilutions. No obvious differences in
growth based on temperature were detected, and therefore only the relative growth of each
strain at 30˚C is presented in Table 4.2. Growth profiles for each of the pcp1 mutations
were similar to that identified previously (Xiao, 2013, see also Figure 2.1 and Table 2.1)
Table 4.2

Respiratory efficiency of pcp1 mutants

Mutation
PCP1 ∆pcp1 G233D G233S G120R G315D S252N
Growth on EG
+++
+
+++
+++
+++
Growth on Glucose +++
++
+++
+++
+++
++
+++
Growth on -His EG plates after 72 hours at 30˚C is reduced or absent in select pcp1
mutants. Growth was scored relative to that of a WT strain on ethanol glycerol (EG) and
glucose using the following scale: +++; WT growth, ++; reduced growth, +; minimal
growth, -; no growth
Data gathered for pcp1 mutants using the serial dilution spotting assay are qualitative
in nature. This is because efficiency of growth is scored using visual approximation of the
density of cell growth at each concentration compared to the density of cell growth by
WT. Sparse growth relative to WT may result from spotting a number of petite cells that
cannot grow on EG or mutant cells that grow inefficiently on EG. Petite yeasts are
characterized by their small colony size and their inability to process non-fermentable
carbon sources for energy, which indicate lack of a functioning electron transport chain.
To quantify the defects found by serial dilution, the petite frequency for each of the strains
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was determined using a replica printing approach. Petite frequency determination is a
quantitative, binary approach to interpreting the ETC functionality of a population of cells,
and it is most helpful in documenting the percentage of cells from a population that have
lost functional mtDNA. Together, the serial dilution spotting assay (Figure 4.1) and petite
frequency determination (Figure 4.2) can be used to gather more descriptive data about the
respiratory efficiency in these mutants that could be gathered with either method alone.
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Petite frequencies of pcp1 mutants

Petite frequencies are elevated in strains whose pcp1 mutations exhibit reduced growth by spotting assay testing.
Overnight cultures for each strain grown in -His liquid media were diluted to a concentration of about 1000 cells per ml. Five 100µl
aliquots of this dilution were spread onto -His glucose plates. After 3 days of growth at 30˚C, the colonies were counted and replica
printed to -His EG plates. After 3 days of growth at 30˚C, the colonies on EG plates were counted. The percentage of colonies from
each strain that grew on -His glucose plates but not -His EG plates represented the petite frequencies. Data are reported as average
petite frequencies +/- one standard deviation.
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Using a two-sample t test to analyze these data, it was determined with 95%
confidence (α = 0.05) that the petite frequencies are significantly different between WT
and all mutants except G233S. There is, however, a statistically significant difference
between the petite frequencies of the two mutants classified as functional, G233S and
S252N, but no statistically significant difference between the petite frequencies of the
partially functional mutants, G120R and G233D. Although normal petite frequencies of
laboratory yeast strains vary significantly depending on the variances of SAL1, CAT5,
MKT1, and MIP1 alleles, strains with the common forms of all of these alleles have <5%
petite frequency (Dimitrov et al., 2009). This is in line with the 3% petite frequency
measured for our WT strain grown under nonselective conditions.

Fold changes in mtDNA/nDNA ratio of pcp1 mutants
Deficiencies in electron transport chain functionality can stem from mutations or
deletions in the mitochondrial genome, which encodes several subunits of the ETC
complex proteins, including cytochrome c oxidase, cytochrome b, and ATP synthase. To
determine whether the increased petite frequencies seen in several of the mutants
mirrored a parallel loss of the mitochondrial genome, the mitochondrial DNA to nuclear
DNA ratios were quantified for each of the five pcp1 mutants and compared to data
obtained for WT, ∆pcp1, and a rho0 strain. The rho0 strain lacks mitochondrial DNA as
confirmed by growth phenotypes and absence of extranuclear DAPI staining. The
primers used to amplify mitochondrial genes were COX1, COX3, and ATP6, each of
which encodes a subunit of a component of the electron transport chain. The degree of
maintenance of such genes may reflect electron transport chain function as previously
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shown by petite frequencies and serial plating (Lezza et al., 1994). Fold changes in the
ratios of mtDNA/nDNA among pcp1mutants were normalized to WT and reported as
ranges in Table 4.3.
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Table 4.3

Fold changes of mtDNA/nDNA

Relative fold changes (average +/- SD) in mtDNA/nDNA normalized to WT (A) and ∆pcp1 (B) were calculated for each of the
mutants, WT, ∆pcp1, and rho0 by real-time PCR. A positive value reflects an increase in mtDNA levels compared to normal, and a
negative value reflects a decrease. Ranges were calculated to three significant digits. Extensive loss of mitochondrial DNA is
observed in the G315D mutant, but it retains more mtDNA than rho0. Data represents results from one biological replicate and only
reactions having an efficiency betwee 102% and 85% were used for analysis. The fold changes were determined from the mean Ct
values of reactions for three mitochondrial targets (COX1, COX3, and ATP6) relative to a single nuclear target (ACT1)

A
Targets
ATP6
(n=3)
COX1
(n=3)
COX3
(n=3)

B

WT
1

∆pcp1
-5,380 to -10,600

rho0
-22,500 to -102,000

G233S
-1.04 to 1.10

Strains
S252N
-1.33 to -1.56

G120R
-1.11 to -1.37

G233D
-1.06 to 1.07

G315D
-3,630 to -11,700

1

-3,840 to -10,200

-10,500 to -32,900

-1.16 to 1.17

-1.30 to -1.70

-1.31 to -1.41

-1.08 to -1.19

-8,580 to -18,200

1

-135 to -181

-11,100 to -22,400

-1.35 to 1.07

-1.37 to -1.67

-1.31 to -1.42

-1.06 to 1.18

-1,930 to -3,200

Targets
ATP6 (n=3)
COX1 (n=3)
COX3 (n=3)

∆pcp1
1
1
1

Strains
rho0
-3.09 to -11.3
-2.12 to -4.50
-78.4 to -129
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G315D
-5.304 to 2.99
-1.62 to -2.70
-20.5 to -12.3

It is evident from these fold changes that there are drastic decreases in the amount of
mtDNA in ∆pcp1 and the strain expressing the G315D Pcp1p mutation. For G315D, this
reduction was as high 18,200-fold. Similarly, mtDNA/nDNA fold changes relative to
WT were also observed in the thousands for ∆pcp1 and rho0. As these fold changes
become arbitrarily large when normalized to WT, it was conducive to renormalize the
fold changes for rho0 and G315D to ∆pcp1. By this method the decrease in
mtDNA/nDNA rations in G315D relative to ∆pcp1 was as high as 20.5-fold. It should be
noted that Ct values gathered during COX1 and ATP6 amplification were consistently
>30 for ∆pcp1, rho0, and G315D, with noticeable variation in the Ct values. This
inevitably lead to large ranges in mtDNA/nDNA fold changes observed for those strains,
which also had the highest reduction in mtDNA template. In addition, this data shows
some fluctuation in the fold change of mtDNA in all other mutants ranging from -1.67 to
1.18 fold relative to WT. As shown in the materials and methods, mtDNA/nDNA fold
changes are calculated using ratios of mitochondrial RCN to nuclear RCN (E∆Ct/E∆Ct).
Assuming the lowest possible percent efficiency, 85% (E = 1.85), for amplification of
both targets, a difference in ∆Ct values of up to 1 cycle resembles mtDNA/nDNA change
of up to 1.85-fold.
FC = 1.85∆Ct/1.85∆Ct = 1.85∆Ct-∆Ct
if ∆Ct - ∆Ct = 1, then FC = 1.851 = 1.85
The Ct values gathered for triplicates from the same strain on a single plate also vary by
less than 1 cycle. Therefore any change in the ratio of mtDNA/nDNA up to 1.85-fold
(i.e., ≤ 1 cycle) should not be considered biologically meaningful. To determine whether
these calculations parallel actual experimental data, the genomic DNA was amplified at
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two different nuclear targets, ACT1 and TIM11, which are located on chromosomes VI
and IV, respectively. The fold changes in nuclear DNA of each of the mutants relative to
WT are reported in Table 4.4.
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Table 4.4

Fold change in nuclear DNA levels

Fold changes in the ratios of TIM11 to ACT1 and TUB2 to ACT1 between pcp1 strains
relative to WT show no correlation to the functionality of the mutant. Fold changes in
nDNA among the pcp1 mutants were obtained from one biological replicate using the
Pfaffl method. Results were normalized to data obtained for the PCP1 WT strain and are
reported as average fold changes +/- standard one standard deviation. A positive value
reflects an increase in mtDNA levels compared to WT, while a negative value reflects a
decrease. Ranges were calculated to three significant digits.

TIM11 (n=2)

WT
1

TUB2 (n=1)

1

G233S
-1.14 to
-1.71
1.04

S252N
-1.06 to
-1.41
-1.08

G120R
-1.41
1.02

G233D
-1.12 to
-1.41
-1.11

G315D
-1.22 to
-1.53
1.02

∆pcp1
-1.33 to
-1.53
-1.02

rho0
-1.32 to
-1.38
1.01

Given that ACT1 and TIM11 are single-copy genes and that the same mass of total
DNA template was used in the qPCR analysis, it is expected that each strain will exhibit
equal amplification of both genes and equal relative fold changes in TIM11/ACT1 DNA
levels. The largest difference in TIM11 DNA/ACT1 DNA ratio relative to the WT strain
was determined to be a 1.71 fold reduction, which was found in the G120R mutant. This
is ≤ 1.85-fold, as predicted using the calculated range of biologically meaningful fold
changes.

Extranuclear DAPI staining indicates mtDNA
Information about the degree of loss in mtDNA in these mutants obtained from qPCR
is limited to the target genes selected for amplification. To holistically assess large-scale
loss of mitochondrial DNA in these pcp1 mutants, total cellular DNA in fixed cells was
stained with DAPI and imaged using fluorescence microscopy. Representative images of
pcp1 mutants stained with DAPI and the percentages of cells from each strain with
mtDNA staining are presented in Figure 4.3.
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Figure 4.3

Fluorescence microscopy of DAPI stained pcp1 mutants
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Figure 4.3 continued
Yeast strains containing the indicated pcp1 mutations were grown overnight in selective
media, fixed in formaldehyde, and stained with DAPI. Photographs were captured using
the same exposure settings for all cells. A population of at least 200 cells was analyzed
from each strain, and the percentages of cells with mtDNA were determined. A cell
containing any extranuclear staining was scored as having mitochondrial DNA. A strain
lacking mtDNA (rho0) was used as a negative control.
Images of cells stained with DAPI revealed that populations of cells from all pcp1
mutant strains have mitochondrial DNA. Approximately 92% of cells with WT
mitochondria showed extranuclear staining. Of the strains, the ones with S252N and
G233S Pcp1p mutants had the highest evidence of mtDNA, with 96% and 94% of cells
showing extranuclear staining, respectively. Pcp1p mutants G233D and G120R had a
significant percentage of cells with extranuclear staining; 82% and 73%, respectively.
Only 62% of cells with the G315D mutant Pcp1p exhibited extranuclear staining.
However, this was noticeably higher than the deletion mutant, which had 35% of cells
with extranuclear staining. Additionally, about 2% of rho0 cells were found to have
extranuclear staining. Extranuclear staining in rho0 cells showed were fewer in number
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and had a lower overall fluorescence intensity than extra nuclear staining in cells from all
other strains.

Analysis of mitochondrial morphology using mtGFP
Phenotypes of cells deleted for Pcp1p or Mgm1p are indistinguishable and have been
shown to accumulate fragmented mitochondria due to defects in mitochondrial fusion
(Herlan et al., 2003). To determine the impact these pcp1 mutations had on
mitochondrial fusion, a TRP1-marked plasmid encoding a mitochondrial-targeted GFP
fusion protein expressed from the constitutive GPD promoter was generated. Maps for
the mtGFP insert, YCplac22 vector, and the final recombinant plasmid used for this
purpose are shown in Figure 4.4.
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Figure 4.4

GFP insert, YCplac22 vector, and final recombinant plasmid maps
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Sequence: YCplac22-GPD-Put2(1-17).dna (Circular / 5543 bp)
Enzymes: Unique 6+ Cutters (46 of 654 total)
Features: 14 visible, 14 total

(5534) BspQI - SapI

B

Unique Cutters Bold

lac operator
M13 rev

(5315) DrdI

HindIII (233)
SnaBI (278)
(5008) AlwNI

NdeI (893)
XbaI (946)
BamHI (952)
TspMI - XmaI (957)
SmaI (959)
Acc65I (961)
KpnI (965)
Eco53kI (969)
SacI (971)
EcoRI (973)

(4529) AhdI
(4463) BsaI

pDG123

KasI (1134)
NarI (1135)
SfoI (1136)
PluTI (1138)

YCplac22-GPD-Put2(1-17)
5543 bp

SpeI (1239)

PflFI - Tth111I (1631)

(3610) AatII
(3608) ZraI
(3549) EcoO109I
(3546) BbsI
(3469) PmlI
(3462) BstZ17I
(3461) AccI

DraIII (2117)

(3353) BstAPI

BsaBI (2205)

(3184) Bsu36I
(3144) EcoRV
(3135) BstXI

NgoMIV (2460)
NaeI (2462)
NheI (2490)
BmtI (2494)

(3018) BsgI
(2992) AarI

BtgZI (2602)

Figure 4.4 continued
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(6301) BspQI - SapI

CAP binding site
lac operator
HindIII (233)
SnaBI (278)

C

XbaI (943)
(5296) AhdI

BtgI - NcoI (1108)
MscI (1113)

pDG371
HpaI (1431)

YCplacc-GPD-Put2(1-17)-GFP

6310 bp

BstBI (1564)
PaeR7I - PspXI - TliI - XhoI (1657)
SalI (1669)

KasI (1901)
NarI (1902)
SfoI (1903)
PluTI (1905)
SpeI (2006)

(4377) AatII
(4375) ZraI
(4316) EcoO109I
(4313) BbsI

TRP1 promoter
(4120) BstAPI
(3951) Bsu36I
(3911) EcoRV
(3902) BstXI

PflFI - Tth111I (2398)

(3785) BsgI
(3759) AarI

(3261) BmtI
(3257) NheI
(3229) NaeI

DraIII (2884)
BsaBI (2972)
NgoMIV (3227)

Figure 4.4 continued
Image A: GFP with a Put2p(1-17) mitochondrial matrix targeting sequence. Put2p(1-17)-GFP encodes GFP(S65T) preceded by the
first 17 amino acids of the mitochondrial targeting sequence on the Put2 protein. This stretch of amino acids has been shown to be
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sufficient for mitochondrial matrix targeting (Gordon et al., 2001). Image B: YCplac22
based vector (pDG123). Image C: Final recombinant plasmid (pDG371) expressed from
the constitutive GPD promoter. In addition to an origin of replication (ori) and a
centromere/autonomous replicating sequence (CEN/ARS), the recombinant plasmid
contains the following selectable markers:
TRP1; encodes phosphoribosylanthranilate isomerase for tryptophan biosynthesis
AMPR; encodes ß-lactamase for antibiotic resistance to ampicillin
Following confirmation of proper plasmid construction, the recombinant plasmid was
transformed into covered DGY539-545 strains. The covering PCP1 plasmid was
removed by counter-selection on media containing 5-FOA, and the expression of GFP in
the uncovered DGY539-545 strains was verified using Western blotting as shown (Figure
4.5).
WT
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GFP expression levels in each pcp1 mutant

All strains express GFP at a similar level. Total protein was isolated from a volume
equivalent to 2 OD600 of cells and protein lysate equal to 0.4 OD600 of cells was
electrophoresed through a 15% SDS-PAGE and transferred to nitrocellulose. GFP and
Pgk1p were detected using monoclonal antibodies directed against GFP and Pgk1p,
respectively. Pgk1p was included to confirm equal protein loading. Lane 1 contains
protein lysate from DGY500, the parental yeast strain lacking the mitochondrial targeted
GFP construct. The migration position of GFP and unprocessed Put2p(1-17)-GFP are
indicated.
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Western analysis of total protein lysates indicates that GFP is expressed in all
strains to similar levels. The two different sizes detected for GFP are due to the lack of
removal of the mitochondrial targeting signal, with the slower migrating species retaining
the Put2p(1-17) targeting sequence. Incomplete removal of Put2p(1-17) could result
from inefficient recognition by the matrix processing peptidase (MPP) or inefficient
trafficking of the recombinant Put2p(1-17)-GFP protein to the mitochondrial matrix.
Considering the constitutive expression of GFP from the GPD promoter, it is likely that
some population of Put2p(1-17)-GFP initiated folding, resulting in the protein adopting a
secondary structure that prohibited it from being translocated fully into mitochondria.
With mtGFP expression in all strains confirmed, the mitochondrial morphology was
determined using fluorescence microscopy. Photographs were taken of >200 cells from
each strain and mitochondrial fragmentation patterns were characterized. Representative
images of fluorescent cells and their tabulated fragmentation patterns are shown in Figure
4.6.
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Fluorescence microscopy of mtGFP in pcp1 mutants
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Figure 4.6 continued
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Figure 4.6 continued
Fewer cells with tubular mitochondria were found in strains expressing a nonfunctional
pcp1 mutant. Images of at least 200 cells from each strain were captured under the same
exposure settings, and the percentages of cells containing GFP localized to tubular
mitochondria, fragmented mitochondria, or the cytosol were determined. A cell that had
at least one tubular mitochondrial structure was classified as tubular (n=1).
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It was found that almost all of the cells expressing WT Pcp1p had tubular
mitochondria (97%), while cells expressing the G233S and S252N mutations had 65%
and 31.5% of cells with tubular mitochondria, respectively. The G233D and G120R
Pcp1p mutants had 13.1% and 1.7% of cells with tubular mitochondria and 52.4% and
87.4% of cells with GFP localized to the cytosol, respectively. In both the deletion
mutant and the G315D Pcp1p mutant, all GFP was improperly targeted to the cytosol
with no mitochondrial structures visible. Therefore, mitochondrial morphology in these
two strains could not be determined using this method. However, Western blot analysis
suggests that there is a population of GFP in these strains that have been processed such
that the mitochondrial targeting sequence was removed. Simultaneous removal of the
targeting sequence and lack of mitochondrial localization of GFP may have resulted from
the translocation of the targeting sequence through the mitochondrial inner membrane but
incomplete transport of the polypeptide due to loss of membrane potential. In this case, a
poor membrane potential may facilitate slow translocation that is sufficient for matrix
targeting sequence cleavage but insufficient to prevent GFP from adopting secondary
structure that prevents its continued translocation ultimately, resulting in a cytosolic
localization.
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CHAPTER V
DISCUSSION
It is conducive to draw conclusions from data about these pcp1 mutants in light of the
locations of the Pcp1p active site amino acids at positions 256 and 313. To a degree, the
data collected in this study support my hypothesis, which stated that a mutation that
introduces a charged amino acid side chain into a transmembrane region (G120R and
G315D) will result in the most noticeable deviations from WT phenotypes in terms of
Pcp1p catalytic activity, respiratory efficiency, mtDNA maintenance, and mitochondrial
morphology, especially if the mutation is in close proximity to an active site as in the
case of G315D. Considering the necessity of hydrophobic interactions in transmembrane
regions to protein folding and function, it is reasonable to infer that different mutations of
the same nature will have a similar effect on the function of not only Pcp1p, but other
rhomboids in general. Interference with substrate recognition and proteolysis resulting
from improper folding are possible mechanisms by which these mutations disrupt Pcp1p
activity. A mutation that introduces a negatively charged residue near an active site, such
as G315D, will inevitable increase electron density in that area. Not only will increased
electron density disrupt hydrophobic interactions near the active site, it may adversely
impact electron flow during proteolysis. Introduction of a charged amino acid in a loop
domain (G233D) was also shown to be antagonistic to Pcp1p function. It is well
established that the conformational flexibility of glycine residues makes it one of the
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most common residues involved in forming tight turns between adjacent antiparallel
strands in a beta-sheet. Assuming that glycine residues also promote formation of turns
connecting adjacent alpha helices, we postulate that the G233D mutation antagonizes
Pcp1p function by disrupting folding at the loop domain. Although this may not directly
impact either of the residues at the active site, it may indirectly reduce proteolysis by
displacing the tertiary structure of Pcp1p enough to hinder recognition of the cleavage
site on Mgm1p. Among the G315D, G120R, and G233D Pcp1p mutants, the most
obvious mutant phenotypes were consistently found in the G315D mutant. All
phenotypes identified for this mutant were comparable to those identified for ∆pcp1. For
both strains ~100% of the cells were petite and had extensive mtDNA loss, while mtGFP
fluorescence microscopy suggested a complete loss in membrane potential in both strains.
Furthermore, Western blot analysis found that only an aberrantly processed s-Mgm1p*
form accumulated in both mutants. Together, this data suggests that Mgm1 processing
by Pcp1p can be completely abolished and many downstream processes extensively
disrupted with the introduction of a single amino acid mutation.
Nuances in the tested phenotypes of the partially functional G233D and G120R
mutants should also be recognized. Both mutants display consistent deviation from WT
phenotypes, with small variations between the two. With the exception of finding an
equivalent percentage of cells with mtDNA in each of these strains, the G120R mutant
displayed slightly healthier phenotypes than the G233D mutant. This coincides with
higher steady-state level of s-Mgm1p* present in the G233D, the accumulation of which
is predicted to have a negative impact on mitochondrial function. The partially functional
phenotype ascribed to the G120R and G233D mutants relative to the nonfunctional
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G315D mutant is likely due to the fact that these two strains accumulate some levels of
the correctly processed short form of Mgm1p.
The G233S and S252N mutants were regarded as functional mutants as they had
phenotypes most similar to WT with regards to Pcp1p catalytic activity, respiratory
efficiency, mtDNA levels, and mitochondrial morphology. Similar to the partially
functional mutants, there are nuances in the phenotypes observed in these two mutants
that also correlate with levels of s-Mgm1p*, which are slightly higher in the S252N
mutant than the G233S mutant. This is most evident in the tabulated analysis of
mitochondrial morphology. The ranked order of the population of cells from the
functional strains that displayed tubular mitochondria was WT > G233S > S252N. This
is an exact inverse to the ranked order of s-Mgm1p* levels, WT<G233S<S252N.
Furthermore, of the functional mutants, a possible indication of loss in membrane
potential was only found in S252N. It should be noted that between these two functional
mutants, with regards to the linear amino acid sequence, only the S252N mutation is in
close proximity to an active site. A BLAST search comparing the amino acid sequences
of Pcp1p to its human analog, Parl, revealed sequence similarities with a large number of
conserved amino acids surrounding the two residues that compose the active site (Figure
5.1). The S252N and G315D mutations are located in two of these conserved positions.
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membrane fusion and membrane bending. Perhaps the aberrant s-Mgm1p* lacks the
GTPase activity necessary to catalyze membrane fusion but also complexes with lMgm1p. If this is found to be true, a model for competitive inhibition of Mgm1p
complex formation that stems from Pcp1p mutations and results in fragmented
mitochondria can be proposed. Alternatively, it is possible that the longer, incorrectly
processed s-Mgm1p* remains tethered to the mitochondrial inner membrane rather than
being released into the IMS as in the case of correct s-Mgm1p. This membrane-tethered
form can also competitively inhibit formation of the proper Mgm1p complex by binding
to either s-Mgm1p or l-Mgm1p. In this scenario the aberrant complex may maintain
GTPase capacity and still not catalyze membrane bending and fusion. Hypothetically,
this could occur if an active GTPase catalytic domain of the s-Mgm1p*/l-Mgm1p
complex is spatially displaced into an inoperative position by its membrane tethering. It
could also occur if the inner membrane anchorage is too pliable for the s-Mgm1p*/sMgm1p complex to promote physical remodeling of the inner membrane. Still another
possibility is that poor mitochondrial fusion is merely a result of decreased s-Mgm1p
levels, which coincide with accumulation of s-Mgm1p*. This scenario may be
distinguished from the others if it is found that introduction of a truncated MGM1 gene
encoding a mitochondrial targeted mature s-Mgm1p resulted in complementation of these
mutant phenotypes.
Past literature has acknowledged a correlation between disruption of Pcp1p activity
and cristae formation, but it is unknown if this is mediated by the Mgm1p complex or by
Tim11p/ATP synthase instability. In fact, it has been shown that ∆pcp1 and ∆mgm1
mutants lack cristae formation, and cytochrome c stored therein may subsequently be
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released into the cytosol (Amutha et al., 2004). In mammalian cells cytochrome c is an
important signaling molecule in caspase-dependent propagation of apoptosis (Liu et al.,
1996). The Pcp1p and Mgm1p human homologs Parl1 and Opa1, which are involved in
ADOA, regulate apoptosis through cytochrome c storage in and release from the cristae.
Published data indicate that degradation of optic nerve fibers in ADOA patients can be
caused by apoptosis of retinal ganglion cells through a cytochrome c dependent pathway
that can be initiated by loss of Parl1 or Opa1 activity (Hill and Pellegrini, 2010; Olichon
et al., 2002). If aberrant s-Mgm1p* lacks GTPase activity necessary for membrane
remodeling, a pathway for cristae loss in yeast may also be elucidated and will likely lead
to a better understanding of cristae loss in human cells.
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CHAPTER VI
CONCLUSION
In summary, I have gathered data that support an inverse correlation between Pcp1p
catalytic activity and numerous indicators of mitochondrial and overall cellular function,
including mitochondrial respiratory efficiency, genome maintenance, tubularization, and
membrane potential. Furthermore, these data indicate that in pathobiology these
correlations are primarily affected by the identity of an amino acid mutation, with more
adverse effects seen in mutations that introduce a novel charge to the enzyme.
Secondarily, these mutations are effected by the proximity of amino acid mutations to the
active sites of Pcp1p at positions 256 and 313. It is apparent that Pcp1p catalytic activity
and the cellular activities named above are also inversely correlated with an incorrectly
processed short Mgm1p isoform, herein identified as s-Mgm1p*. This s-Mgm1p* was
shown to accumulate in the mitochondria in the absence of fully functional Pcp1p, and, in
fact, strains deleted for the enzyme were found to have only this incorrectly processed
short isoform. Mitochondrial membrane fusion in yeast is thought to depend in part on
the anchor-GTPase enzyme complex formed by association of short and long Mgm1p
(Schrempp and van der Laan, 2015). It stands to reason that disruption of this complex
may negatively impact all downstream events that rely on mitochondrial fusion. No
known role for s-Mgm1p* has been established. In light of the correlation between this
aberrant short form and adverse downstream cellular phenotypes, my data warrants
further investigation into biochemical properties and generation of s-Mgm1p*,
specifically the enzyme responsible for this aberrant processing and the catalytic activity
associated with this misprocessed s-Mgm1p*, if any. This information will lead to a
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more complete understanding of the cellular order of events that occurs in S. cerevisiae
when Pcp1p catalytic activity is knocked down. It may also result in a better
understanding of the pathobiology that results in apoptotic degeneration of retinal cells
when Parl function is knocked down in human ADOA patients. As there is currently no
known cure for ADOA, it is imperative to understand the disease’s pathobiology as
extensively as possible.
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APPENDIX
Tables
Table 6.1

Saccharomyces cerevisiae strains used

Strain
Name
DGY24
DGY43

Plasmid
NA
pDG103

Genotype
a his3∆1, leu2∆0, ura3∆0, met15∆0, rho0
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

Generated
(Xiao 2013)
(Xiao 2013)

DGY500

pDG103

(Xiao 2013)

DGY519

pDG96

DGY520

pDG331

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2, ∆trp1::KanR
a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

DGY521

pDG338

a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

In this study

DGY522

pDG343

a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

In this study

DGY523

pDG351

a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

In this study

DGY524

pDG349

a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

In this study

DGY525

pDG345

a his3∆1, leu2∆0, ura3∆0, met15∆0,
∆trp::KanR ϒpcp1::LEU2

In this study

DGY528

pDG371,
pDG103

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

DGY529

pDG331,
pDG103,
pDG371
pDG338,
pDG103,
pDG371

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

DGY530

58

In this study
In this study

DGY531

DGY532

DGY533

DGY534

DGY539
DGY540
DGY541
DGY542
DGY543
DGY544
DGY545

Table 6.2

pDG343,
pDG103,
pDG371
pDG345,
pDG103,
pDG371
pDG349,
pDG103,
pDG371
pDG351,
pDG103,
pDG371
pDG96,
pDG103
pDG331,
pDG103
pDG338,
pDG103
pDG343,
pDG103
pDG345,
pDG103
pDG349,
pDG103
pDG351,
pDG103

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study

a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2
a his3∆1, leu2∆0, ura3∆0, met15∆0,
ϒpcp1::LEU2

In this study
In this study
In this study
In this study
In this study
In this study
In this study

Plasmids used in this study

Plasmid

Description

Generated

pDG96

pRS413, CEN/ARS, AmpR, HIS3 (deleted for Pcp1p)

pDG103

pRS416-GPDpromoter-PCP1, CEN/ARS, AmpR, URA3

pDG123

YCplac22-GPDpromoter-Put21-17 ∆33Nm23H4:HA3,
CEN/ARS, AmpR,, TRP1
pFA6a-KanMX6

(Sikorski and
Hieter 1989)
Gordon Lab,
unpublished
Gordon Lab,
unpublished
(Longtine, 1998)

pDG271
pDG331

pRS413-PCP1promoter-PCP1:HA3, CEN/ARS, AmpR,
HIS3 (WT Pcp1p)
59

(Xiao, 2013)

pDG338
pDG343
pDG345
pDG349
pDG351
pDG371

pRS413-PCP1promoter-PCP1 G755A:HA3, CEN/ARS,
AmpR, HIS3 (S252N)
pRS413-PCP1promoter-PCP1 G697A T962C:HA3,
CEN/ARS, AmpR, HIS3 (G233S)
pRS413-PCP1promoter-PCP1 G358A:HA3, CEN/ARS,
AmpR, HIS3 (G120R)
pRS413-PCP1promoter-PCP1 G698A:HA3, CEN/ARS,
AmpR, HIS3 (G233D)
pRS413-PCP1promoter-PCP1 G944T:HA3, CEN/ARS,
AmpR, HIS3 (G315D)
YCplac22-GPDpromoter-Put2(1-17)-GFP, TRP1,
CEN/ARS, AmpR

60

(Xiao, 2013)
(Xiao, 2013)
(Xiao, 2013)
(Xiao, 2013)
(Xiao, 2013)
In this study

